{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:20:49Z","timestamp":1787775649439,"version":"build-2784847793"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Nystagmus, characterized by involuntary ocular movements, presents significant challenges in both congenital and acquired forms, often significantly impacting visual acuity and quality of life. This comprehensive review examines the current landscape of pharmacological interventions for nystagmus, highlighting several key drug classes and their mechanisms of action. To identify relevant studies, an extensive literature search was conducted in PubMed, Web of Science, and Scopus, covering English-language articles from 1960 to 2025. Gabapentin, a calcium channel blocker with potential effects on gamma-aminobutyric acid (GABA) activity, and baclofen, a GABAergic agent, have shown promise in treating both congenital and acquired forms, whereas glutamate antagonists like memantine have demonstrated efficacy in some cases. Potassium channel blockers, including aminopyridines, have proven especially effective for certain acquired nystagmus types, particularly downbeat nystagmus. The potential of anticholinergic drugs and benzodiazepines in specific nystagmus subtypes is also discussed. Efficacy often varies among individuals, highlighting the need for personalized approaches. This review underscores the importance of both nystagmus reduction and preservation of normal eye movements. Although many medications show promise, most studies have small sample sizes and lack long-term data, making direct comparisons challenging. Therefore, further research (particularly large-scale randomized controlled trials) is needed to support the development of novel targeted therapies, including combination treatments or adjunctive nonpharmacological approaches, to improve management of this complex condition.<\/jats:p>","DOI":"10.4103\/ojo.ojo_246_25","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:00:19Z","timestamp":1772218819000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological management of nystagmus: An in-depth review for clinical practice"],"prefix":"10.4103","volume":"19","author":[{"given":"Hassan","family":"Asadigandomani","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Kazemian","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khorrami-Nejad","sequence":"additional","affiliation":[{"name":"Department of Optometry, School of Rehabilitation, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaid Sulaiman","family":"Al Kalbani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, School of Medicine, Oman Medical Specialty Board, Al Nahdha Hospital, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Masoomian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"R1-20260302","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00055735-200110000-00010","article-title":"Nystagmus","volume":"12","author":"Gottlob","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20260302","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1167\/iovs.09-3486","article-title":"The prevalence of nystagmus: The Leicestershire nystagmus survey","volume":"50","author":"Sarvananthan","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20260302","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/08820530600614181","article-title":"Visual and perceptual consequences of congenital nystagmus","volume":"21","author":"Bedell","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"R4-20260302","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.oftal.2017.06.001","article-title":"Topical brinzolamide in congenital nystagmus: A retrospective study","volume":"92","author":"Nieves-Moreno","year":"2017","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R5-20260302","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.21065","article-title":"Congenital nystagmus: Randomized, controlled, double-masked trial of memantine\/gabapentin","volume":"61","author":"McLean","year":"2007","journal-title":"Ann Neurol"},{"key":"R6-20260302","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjo.2005.086322","article-title":"The effects of gabapentin and memantine in acquired and congenital nystagmus: A retrospective study","volume":"90","author":"Shery","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R7-20260302","doi-asserted-by":"crossref","first-page":"14","DOI":"10.51847\/kqbONHsU0o","article-title":"Effectiveness of botulinum toxin (botox) for treatment of nystagmus: A review","volume":"13","author":"Al Hemaidi","year":"2024","journal-title":"World J Environ Biosci"},{"key":"R8-20260302","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09273970601026045","article-title":"Baclofen for patients with congenital periodic alternating nystagmus","volume":"14","author":"Comer","year":"2006","journal-title":"Strabismus"},{"key":"R9-20260302","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.21991","article-title":"Crossover trial of gabapentin and memantine as treatment for acquired nystagmus","volume":"67","author":"Thurtell","year":"2010","journal-title":"Ann Neurol"},{"key":"R10-20260302","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007728","article-title":"Drug therapy for acquired pendular nystagmus in multiple sclerosis","volume":"244","author":"Starck","year":"1997","journal-title":"J Neurol"},{"key":"R11-20260302","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1167\/iovs.16-21308","article-title":"Effect of gabapentin\/memantine on the infantile nystagmus syndrome in the zebrafish model: Implications for the therapy of ocular motor diseases","volume":"58","author":"B\u00f6gli","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20260302","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WNO.0000000000000807","article-title":"Gabapentin and memantine for treatment of acquired pendular nystagmus: Effects on visual outcomes","volume":"40","author":"Nerrant","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"R13-20260302","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3988\/jcn.2021.17.3.337","article-title":"Update on nystagmus and other ocular oscillations","volume":"17","author":"Jeong","year":"2021","journal-title":"J Clin Neurol"},{"key":"R14-20260302","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00415-009-5309-x","article-title":"Acquired pendular nystagmus in multiple sclerosis: An examiner-blind cross-over treatment study of memantine and gabapentin","volume":"257","author":"Starck","year":"2010","journal-title":"J Neurol"},{"key":"R15-20260302","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/014107680209500505","article-title":"Medical treatment of nystagmus and its visual consequences","volume":"95","author":"Stahl","year":"2002","journal-title":"J R Soc Med"},{"key":"R16-20260302","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ana.410410620","article-title":"A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus","volume":"41","author":"Averbuch-Heller","year":"1997","journal-title":"Ann Neurol"},{"key":"R17-20260302","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/00005537-200108000-00029","article-title":"Role of clonazepam in the treatment of idiopathic downbeat nystagmus","volume":"111","author":"Young","year":"2001","journal-title":"Laryngoscope"},{"key":"R18-20260302","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/WNL.41.11.1737","article-title":"Effect of anticholinergic agents upon acquired nystagmus: A double-blind study of trihexyphenidyl and tridihexethyl chloride","volume":"41","author":"Leigh","year":"1991","journal-title":"Neurology"},{"key":"R19-20260302","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.71.1.107","article-title":"Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis?","volume":"71","author":"Bandini","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-20260302","doi-asserted-by":"crossref","first-page":"921341","DOI":"10.3389\/fneur.2022.921341","article-title":"A 6-month trial of memantine for nystagmus and associated phenomena in oculopalatal tremor","volume":"13","author":"Martins","year":"2022","journal-title":"Front Neurol"},{"key":"R21-20260302","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","article-title":"Treatment of downbeat nystagmus with 3,4-diaminopyridine: A placebo-controlled study","volume":"61","author":"Strupp","year":"2003","journal-title":"Neurology"},{"key":"R22-20260302","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.2004.045716","article-title":"4-aminopyridine restores visual ocular motor function in upbeat nystagmus","volume":"76","author":"Glasauer","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-20260302","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","article-title":"The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus","volume":"54","author":"Dieterich","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-20260302","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0161-6420(86)33640-6","article-title":"The use of clonazepam in the treatment of nystagmus-induced oscillopsia","volume":"93","author":"Currie","year":"1986","journal-title":"Ophthalmology"},{"key":"R25-20260302","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.410350312","article-title":"Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: A double-blind, randomized trial of three intravenous drugs","volume":"35","author":"Barton","year":"1994","journal-title":"Ann Neurol"},{"key":"R26-20260302","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/WNL.53.9.2209-a","article-title":"Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis","volume":"53","author":"Schon","year":"1999","journal-title":"Neurology"},{"key":"R27-20260302","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.37.5.887","article-title":"Ethanol-induced resolution of pathologic nystagmus","volume":"37","author":"Lepore","year":"1987","journal-title":"Neurology"},{"key":"R28-20260302","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/19585969.2023.2231466","article-title":"Suicidality risk after using cannabis and cannabinoids: An umbrella review","volume":"25","author":"Shamabadi","year":"2023","journal-title":"Dialogues Clin Neurosci"},{"key":"R29-20260302","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.2007.126284","article-title":"Downbeat nystagmus: Aetiology and comorbidity in 117 patients","volume":"79","author":"Wagner","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R30-20260302","doi-asserted-by":"crossref","first-page":"111146","DOI":"10.1016\/j.jocn.2025.111146","article-title":"Environmental risk factors of late-onset multiple sclerosis: A population-based case-control study","volume":"135","author":"Kasbi","year":"2025","journal-title":"J Clin Neurosci"},{"key":"R31-20260302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17469899.2025.2489737","article-title":"Current treatment and management of neuromyelitis optica spectrum disorder: Areas for improvement","volume":"20","author":"Jahani","year":"2025","journal-title":"Expert Rev Ophthalmol"},{"key":"R32-20260302","doi-asserted-by":"crossref","first-page":"e70439","DOI":"10.1002\/brb3.70439","article-title":"Uncovering the causal link between obesity-associated genes and multiple sclerosis: A systematic literature review","volume":"15","author":"Jafari","year":"2025","journal-title":"Brain Behav"},{"key":"R33-20260302","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10072-024-07746-8","article-title":"The coincidence of multiple sclerosis and primary vasculitis;from the bench of pathology to the bedside of treatment: A systematic review of case reports","volume":"46","author":"Bafrani","year":"2025","journal-title":"Neurol Sci"},{"key":"R34-20260302","doi-asserted-by":"crossref","first-page":"104610","DOI":"10.1016\/j.msard.2023.104610","article-title":"The National Multiple Sclerosis Registry System of Iran (NMSRI): Aspects and methodological dimensions","volume":"72","author":"Ayoubi","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"R35-20260302","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jns.2018.05.002","article-title":"Paraneoplastic seesaw nystagmus and opsoclonus provides evidence for hyperexcitable reciprocally innervating mesencephalic network","volume":"390","author":"Rizvi","year":"2018","journal-title":"J Neurol Sci"},{"key":"R36-20260302","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNO.0000000000000575","article-title":"Pendular seesaw nystagmus in a patient with a giant pituitary macroadenoma: Pathophysiology and the role of the accessory optic system","volume":"38","author":"Yat-Ming","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"R37-20260302","first-page":"484","article-title":"See-saw nystagmus. Clinical aspects, diagnosis, pathophysiology: Observations in 2 patients","volume":"67","author":"Endres","year":"1996","journal-title":"Nervenarzt"},{"key":"R38-20260302","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/aian.AIAN_290_21","article-title":"Concurrent periodic alternating gaze deviation and periodic alternating nystagmus in brainstem glioma","volume":"25","author":"Maramattom","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"R39-20260302","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/WNO.0000000000001739","article-title":"Treatment of periodic alternating nystagmus as a consequence of ataxia-telangiectasia","volume":"44","author":"Jauregui","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"R40-20260302","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/WNO.0000000000000507","article-title":"Ocular motor manifestations of multiple sclerosis","volume":"37","author":"Nerrant","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"R41-20260302","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/WNF.0b013e3181873697","article-title":"Treatment of acquired periodic alternating nystagmus with memantine: A case report","volume":"32","author":"Kumar","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"R42-20260302","first-page":"1","article-title":"Diagnostic criteria for central versus peripheral positioning nystagmus and vertigo: A review","volume":"119","author":"B\u00fcttner","year":"1999","journal-title":"Acta Otolaryngol"},{"key":"R43-20260302","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3988\/jcn.2025.0105","article-title":"Usefulness of nystagmus patterns in distinguishing peripheral from central acute vestibular syndromes at the bedside: A critical review","volume":"21","author":"Lee","year":"2025","journal-title":"J Clin Neurol"},{"key":"R44-20260302","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/00016489.2010.531052","article-title":"Which medication do I need to manage dizzy patients?","volume":"131","author":"Huppert","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"R45-20260302","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1756285609103120","article-title":"Current treatment of vestibular, ocular motor disorders and nystagmus","volume":"2","author":"Strupp","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"R46-20260302","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcjo.2015.07.010","article-title":"Infantile nystagmus syndrome: Clinical characteristics, current theories of pathogenesis, diagnosis, and management","volume":"50","author":"Richards","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"R47-20260302","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/aos.14354","article-title":"Prevalence and causes of infantile nystagmus in a large population-based Danish cohort","volume":"98","author":"Hvid","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R48-20260302","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1055\/a-1525-0030","article-title":"Nystagmus: Diagnosis, topographic anatomical localization and therapy","volume":"238","author":"Strupp","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"R49-20260302","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WNO.0b013e3182236427","article-title":"Effects of topical brinzolamide on infantile nystagmus syndrome waveforms: Eyedrops for nystagmus","volume":"31","author":"Dell'osso","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R50-20260302","doi-asserted-by":"crossref","first-page":"fcad239","DOI":"10.1093\/braincomms\/fcad239","article-title":"Spinocerebellar ataxia 27B: Episodic symptoms and acetazolamide response in 34 patients","volume":"5","author":"Ashton","year":"2023","journal-title":"Brain Commun"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_246_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:37:33Z","timestamp":1787773053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_246_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_246_25","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-06-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}